| 
						Ottobock reaches for growth with industrial exoskeletons
		 Send a link to a friend 
		
		 [September 11, 2018] 
		 By Caroline Copley 
 BERLIN (Reuters) - German artificial limb 
		manufacturer Ottobock <IPO-OBH.F> plans to start selling a mechanical 
		exoskeleton that makes manual labor for factory workers easier this 
		week, joining a field already crowded with major industrial players and 
		start-ups.
 
 The 99-year-old firm, which started out making prosthetics for World War 
		One veterans, is seeking to tap new growth opportunities ahead of a 
		possible stock market listing.
 
 The family-owned company has tested the 'Paexo', a wearable upper-body 
		exoskeleton designed to ease the physical strain of repetitive overhead 
		assembly work, on 30 workers at a Volkswagen <VOWG_p.DE> plant in 
		Bratislava.
 
 After 80 percent of workers said they would recommend it to colleagues, 
		Ottobock is talking to Volkswagen about using the Paexo in series 
		production, said Soenke Roessing, head of Ottobock's Industrials unit.
 
 VW said it was in final consultations about rolling out the exoskeleton 
		in series production.
 
 Exoskeletons were developed for medical and military use. But as workers 
		age, sales of exoskeletons for industry are forecast to rise to $1.76 
		billion in 2028 from $67.29 million this year, according Rian Whitton, 
		an analyst at technology market intelligence firm ABI Research.
 
		
		 
		This corresponds to more than 126,000 units in 2028, against around 
		3,900 this year, as companies seek to make workers more productive and 
		protect them from injury.
 Ottobock plans to launch the Paexo on Thursday. Beyond the automotive 
		sector, it is targeting the aerospace, shipping and construction 
		industries as well as tradespeople, and is running pilots at over 20 
		sites in Europe, Roessing said.
 
 Hans Georg Naeder, grandson of Ottobock's founder, sold a 20 percent 
		stake to Swedish private equity firm EQT last year aiming to increase 
		the company's value ahead of a possible IPO.
 
 Since then, Ottobock, which had sales of 927.4 million euros ($1.08 
		billion) in 2017, has revamped its management with Naeder appointing 
		Oliver Scheel as CEO, the first non-family member to run the company.
 
 Ottobock began by developing exoskeletons to help people with partial 
		paralysis or spinal injury walk again. Its move into industry is part of 
		a broader bet on bionics - using mechanics to augment human strength.
 
 It will not be alone. A host of new start-ups, including Dutch firm 
		Laevo and California's SuitX, are racing more established players in the 
		defense and engineering space, such as Lockheed Martin <LMT.N> and 
		Panasonic <6752.T>.
 
 Ottobock's closest competitor, Iceland's Ossur <OSSR.CO>, has teamed up 
		with Fiat Chrysler's <FCHA.MI> robotics specialist Comau and plans to 
		launch an upper-body exoskeleton in December.
 
 Other car companies are testing the technology too.
 
 Ford Motor Co <F.N> started testing upper-body skeletons developed by 
		Ekso Bionics Holdings <EKSO.O> at two U.S. factories last year. 
		Meanwhile workers at BMW's <BMWG.DE> Spartanburg factory in the United 
		States have trialed an exoskeleton vest from Levitate Technologies.
 
		
            [to top of second column] | 
            
			 
            
			Soenke Rossing, Head of Industrials unit at German prosthetic limb 
			maker Ottobock, presents an exoskeleton of the company during an 
			interview with Reuters in Berlin, Germany, August 23, 2018. 
			REUTERS/Hannibal Hanschke 
            
			 
Audi <NSUG.DE> is rolling out a "Chairless Chair" exoskeleton made by Swiss 
start-up Noonee that allows workers to sit instead of standing at its Ingolstadt 
factory.
 It has also tested upper-body exoskeletons from Laevo and is planning a 
comparative study with Ottobock's Paexo and Levitate's Airframe later this year.
 
 HUMAN-ROBOT COLLABORATION
 
 Patrick Schwarzkopf, managing director of the VDMA Robotics + Automation 
Association, said the scramble to develop exoskeletons underscored a trend 
towards closer interaction between humans and machines in factories.
 
 "An exoskeleton is probably the most intense form of human-robot collaboration. 
In a way, your arm becomes a robot arm because it has reinforced strength," he 
said.
 
Schwarzkopf sees exoskeletons competing with inexpensive collaborative robots, 
or "cobots", which can work alongside humans, for example placing a tyre on a 
vehicle while leaving the worker to screw it into place.
 A cobot can cost as little as $10,000, although they typically cost two to three 
times that. Ottobock's Paexo is priced at 5,000 euros.
 
 The Paexo is a 'passive' exoskeleton that works by transferring the weight of 
the raised arms to the hips through a mechanical cable technology that takes the 
stress off a worker's shoulders.
 
 The backpack weighs 1.9 kilograms and gives the user's arms a feeling of 
weightlessness akin to floating in a swimming pool.
 
Roessing said the Paexo was the lightest of its kind and can be worn for 
eight-hour shifts, allowing workers to hold heavy tools or screw in parts 
overhead without strain. To make his point, he wore the Paexo throughout an 
interview with Reuters. 
 
Juergen Klippert, an expert on the future of work at the IG Metall union, said 
exoskeletons ostensibly provided relief. But it was unclear whether a worker's 
joints would be burdened by holding heavy tools for prolonged periods.
 Ottobock plans to make its exoskeletons "intelligent" by adding sensors to help 
workers correct their posture and tell them what part to place where in the 
assembly process. Prototypes to support the back and hand are also in 
development.
 
 After colleagues kept asking to borrow the 'Paexo' for the weekend to do home 
renovations, Roessing now wants to launch a simplified version for the price of 
a good power tool.
 
 ($1 = 0.8587 euros)
 
 (Reporting by Caroline Copley; Editing by Giles Elgood)
 
				 
			[© 2018 Thomson Reuters. All rights 
				reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |